|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.415 USD | +1.03% |
|
-5.11% | -24.74% |
| 06-18 | Coya Therapeutics Presents Alstars Trial Design At Encals 2026 Meeting | CI |
| 06-08 | Coya Therapeutics Says Phase 2 ALS Study Enters Blinded Extension Phase | MT |
| Market Cap | 103M 90.16M 83.75M 77.03M 144M 9.93B 147M 1B 391M 4.84B 385M 377M 16.8B | P/E 2026 * |
-3.22x | P/E 2027 * | -3.15x |
|---|---|---|---|---|---|
| Enterprise Value | 103M 90.16M 83.75M 77.03M 144M 9.93B 147M 1B 391M 4.84B 385M 377M 16.8B | EV / Sales 2026 * |
43.7x | EV / Sales 2027 * | 20.7x |
| Free-Float |
82.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Coya Therapeutics, Inc.
| 1 day | +0.92% | ||
| 1 week | -5.11% | ||
| Current month | -25.38% | ||
| 1 month | -19.02% | ||
| 3 months | +0.58% | ||
| 6 months | -7.52% | ||
| Current year | -24.74% |
| 1 week | 4.24 |  | 4.72 |
| 1 month | 4.24 | | 6.21 |
| Current year | 3.71 | | 6.21 |
| 1 year | 3.71 | | 7.75 |
| 3 years | 3.21 | | 10.69 |
| 5 years | 3.21 | | 10.69 |
| 10 years | 3.21 | | 10.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arun Swaminathan
CEO | Chief Executive Officer | 57 | 2024-10-31 |
Fred Grossman
PSD | President | 67 | 2023-07-16 |
David Snyder
DFI | Director of Finance/CFO | 65 | 2022-03-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Dov Goldstein
BRD | Director/Board Member | 58 | 2021-02-28 |
| Director/Board Member | 67 | 2021-05-24 | |
Ann Lee
BRD | Director/Board Member | 64 | 2021-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 4/9/26 | Free | Director | 10,000 | 0.0426% | ||
| 1/22/26 | Free | Chief Executive Officer | 293,983 | 1.4050% | ||
| 1/22/26 | Free | Chairperson | 140,041 | 0.6693% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.03% | -5.11% | -28.09% | +7.25% | 103M | |
| +1.08% | -5.74% | -4.98% | +11.68% | 46.06B | |
| +3.08% | +5.69% | +404.60% | +630.05% | 38.91B | |
| +2.00% | +3.22% | +11.13% | +67.82% | 35.57B | |
| +4.19% | -1.85% | +6.36% | -9.45% | 33.13B | |
| +1.23% | -1.99% | -0.05% | +30.76% | 26.42B | |
| +0.05% | -2.61% | - | - | 16.61B | |
| +14.65% | +12.66% | +38.54% | +145.40% | 15.08B | |
| -6.32% | -4.59% | +4.36% | +8.22% | 14.08B | |
| +1.68% | +0.06% | +1.31% | -29.90% | 12.81B | |
| Average | +2.23% | -2.88% | +48.13% | +95.76% | 23.88B | |
| Weighted average by Cap. | +2.36% | -2.47% | +75.51% | +134.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.35M 2.06M 1.92M 1.76M 3.31M 227M 3.37M 22.94M 8.95M 111M 8.81M 8.62M 385M | 4.96M 4.36M 4.05M 3.73M 6.99M 481M 7.12M 48.48M 18.91M 234M 18.63M 18.22M 813M |
| Net income | -30.98M -27.24M -25.31M -23.28M -43.65M -3B -44.44M -303M -118M -1.46B -116M -114M -5.08B | -32.16M -28.29M -26.28M -24.17M -45.33M -3.11B -46.14M -314M -123M -1.52B -121M -118M -5.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | US$4.365 | -0.11% | 183,991 |
| 26-07-22 | US$4.370 | -3.96% | 143,266 |
| 26-07-21 | US$4.550 | +2.48% | 257,674 |
| 26-07-20 | US$4.440 | -2.20% | 245,942 |
| 26-07-17 | US$4.540 | -1.30% | 361,179 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COYA Stock
Select your edition
All financial news and data tailored to specific country editions
